Table: RaQualia Pharma - 9-MTH group results

RaQualia Pharma

12/11/2021 06:01

Nov 12 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2021        Sep 30, 2020     Dec 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               1.62               573 mln           2.25     
                  (+183.0 pct)         (-19.0 pct)     (+102.9 pct) 
  Operating          107 mln          loss 600 mln        61 mln    
  Recurring          238 mln          loss 615 mln        184 mln   
  Net                169 mln          loss 698 mln        118 mln   
  EPS               8.08 yen         loss 33.35 yen      5.65 yen   
  EPS Diluted       8.08 yen                                        
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T